Drugs / CBD
last change Feb 2019 re-read 3 minutes ago

CBD

Developed for
chronic pain syndrome
Investigated by
Santé Cannabis · Tetra Bio-Pharma

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03337503 Jan 2018 → Feb 2019 chronic pain syndrome Santé Cannabis Terminated No outcome recorded Stop: Business

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CBD “2.5 mg THC with 2.5 mg CBD capsule” NCT03337503 ↗